Evidence map›Paper›PMID 36225861›Full record

ArticleClinical medicine insights. Case reports2022

Mild Facial Paresis in a Recipient of Gam-COVID-Vac Vaccine: A Case Report.

Negin Mahmoudi Hamidabad, Amir Reza Mafi, Meysam Abolmaali

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical medicine insights. Case reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 3 citations in OpenAlex.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Negin Mahmoudi HamidabadDepartment of Neurology, Firoozgar Hospital, Iran University of Medical Sciences, Tehran, Iran.ORCID https://orcid.org/0000-0003-2590-2943
Amir Reza MafiFarabi Eye Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Meysam AbolmaaliShefa Neuroscience Research Center, Khatam Alanbia Hospital, Tehran, Iran.
Farabi Hospital · IRIran University of Medical Sciences · IRKhatam University · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Facial paralysis has been reported as a rare side effect of mRNA COVID-19 vaccines. The Gam-COVID-Vac was introduced in August 2020 in Russia. There was no report of facial paralysis in phase I to III clinical trials of the vaccine. To our knowledge, there is no post-marketing report of facial paresis with Gam-COVID-Vac vaccination to this date. The Gam-COVID-Vac vaccine has a reported efficacy of 90%, but its safety and efficacy have not been approved by international organizations to this date. Iran is among the countries using the Gam-COVID-Vac vaccine. Here, we present a case of mild facial paresis that occurred shortly after the Gam-COVID-Vac vaccine administration in a female healthcare worker.

Indexed as

COVID-19 vaccinefacial paresisGam-COVID-Vac

Identifiers

PMID36225861
PMCPMC9548508
OpenAlexW4306168024

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.